These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 8164448)

  • 41. The efficacy and safety of tacrolimus monotherapy in adult-onset nephrotic syndrome caused by idiopathic membranous nephropathy.
    Liang Q; Li H; Xie X; Qu F; Li X; Chen J
    Ren Fail; 2017 Nov; 39(1):512-518. PubMed ID: 28562168
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pulmonary embolism as a presentation of nephrotic syndrome].
    Fraisse C; Nouvier M; Lainez S; Nesme P; Ernesto S; Devouassoux G
    Rev Mal Respir; 2017 Sep; 34(7):765-769. PubMed ID: 28844809
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasma total homocysteine concentration in nephrotic patients with idiopathic membranous nephropathy.
    Arnadottir M; Hultberg B; Berg AL
    Nephrol Dial Transplant; 2001 Jan; 16(1):45-7. PubMed ID: 11208992
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thromboembolic phenomena in patients with nephrotic syndrome: pathophysiology, risk factors, prophylaxis and treatment.
    Wang SS; Tang H; Ng HY; Lian JJ; Javaid MM
    Br J Hosp Med (Lond); 2024 Jan; 85(1):1-10. PubMed ID: 38300681
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chylous ascites in an adult patient with nephrotic syndrome due to membranous nephropathy.
    Kato A; Kohno S; Ohtake T; Takita T; Hirshida A
    Nephron; 2001 Nov; 89(3):361-2. PubMed ID: 11598407
    [No Abstract]   [Full Text] [Related]  

  • 46. Safety of Rituximab Compared with Steroids and Cyclophosphamide for Idiopathic Membranous Nephropathy.
    van den Brand JAJG; Ruggenenti P; Chianca A; Hofstra JM; Perna A; Ruggiero B; Wetzels JFM; Remuzzi G
    J Am Soc Nephrol; 2017 Sep; 28(9):2729-2737. PubMed ID: 28487395
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Tacrolimus combined with corticosteroids in treatment of nephrotic idiopathic membranous nephropathy: a multicenter randomized controlled trial.
    Chen M; Li H; Li XY; Lu FM; Ni ZH; Xu FF; Li XW; Chen JH; Wang HY;
    Am J Med Sci; 2010 Mar; 339(3):233-8. PubMed ID: 20220333
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thrombotic complications in childhood-onset idiopathic membranous nephropathy.
    Louis CU; Morgenstern BZ; Butani L
    Pediatr Nephrol; 2003 Dec; 18(12):1298-300. PubMed ID: 14586672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nephrotic syndrome and anticoagulant therapy.
    Kaizu K; Etoh S
    Intern Med; 1998 Feb; 37(2):210-2. PubMed ID: 9550613
    [No Abstract]   [Full Text] [Related]  

  • 50. Bilateral Renal Vein Thrombosis in Membranous Nephropathy: Hypoalbuminemia Predictive of Venous Thromboembolism in Nephrotic Syndrome.
    Casey D; Romero K; Patel R; Ouellette T; Anasseri S; Eftekhari P
    Cureus; 2022 Oct; 14(10):e30032. PubMed ID: 36348912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Membranous nephropathy in the older adult: epidemiology, diagnosis and management.
    Deegens JK; Wetzels JF
    Drugs Aging; 2007; 24(9):717-32. PubMed ID: 17727303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Three patients with nephrotic syndrome due to membranous nephropathy complicated by Sjögren's syndrome].
    Baba A; Hara S; Sato Y; Yamada K; Fujimoto S; Eto T
    Nihon Jinzo Gakkai Shi; 2005; 47(8):882-6. PubMed ID: 16408433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypercoagulability and nephrotic syndrome.
    Gigante A; Barbano B; Sardo L; Martina P; Gasperini ML; Labbadia R; Liberatori M; Amoroso A; Cianci R
    Curr Vasc Pharmacol; 2014 May; 12(3):512-7. PubMed ID: 22724465
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A feasibility study of continuing dose-reduced warfarin for invasive procedures in patients with high thromboembolic risk.
    Larson BJ; Zumberg MS; Kitchens CS
    Chest; 2005 Mar; 127(3):922-7. PubMed ID: 15764777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunosuppressive treatment for idiopathic membranous nephropathy in adults with nephrotic syndrome.
    Schieppati A; Perna A; Zamora J; Giuliano GA; Braun N; Remuzzi G
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004293. PubMed ID: 15495098
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mizoribine therapy combined with steroids and mizoribine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome.
    Saito T; Iwano M; Matsumoto K; Mitarai T; Yokoyama H; Yorioka N; Nishi S; Yoshimura A; Sato H; Ogahara S; Sasatomi Y; Kataoka Y; Ueda S; Koyama A; Maruyama S; Nangaku M; Imai E; Matsuo S; Tomino Y;
    Clin Exp Nephrol; 2017 Dec; 21(6):961-970. PubMed ID: 27783276
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Burden of potentially avoidable anticoagulant-associated hemorrhagic and thromboembolic events in the elderly.
    van Walraven C; Oake N; Wells PS; Forster AJ
    Chest; 2007 May; 131(5):1508-15. PubMed ID: 17317732
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Severe nephrotic syndrome with reversible acute kidney failure in lupus-associated membranous nephropathy].
    Pauli-Magnus C; Mettang T; Kuhlmann U
    Dtsch Med Wochenschr; 1999 Jun; 124(25-26):788-92. PubMed ID: 10414228
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dramatic remission of nephrotic syndrome after unusual complication of mucormycosis in idiopathic membranous nephropathy.
    Ye W; Wang Y; Wen Y; Li H; Li X
    Int Urol Nephrol; 2014 Jun; 46(6):1247-51. PubMed ID: 24414303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Membranous nephropathy associated with ovarian tumour in a young girl: recovery after removal.
    Beauvais P; Vaudour G; Boccon Gibod L; Levy M
    Eur J Pediatr; 1989 Jun; 148(7):624-5. PubMed ID: 2663514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.